HIV & Bone Damage

HIV & Bone Damage Photo

Expanding bone mineralization variations from the norm saw among individuals living with HIV (PLWHIV) result from different components identifying with the host, the infection, and the antiretrovirals utilized. Today, HIV infection is considered to be a risk factor for bone mineralization disorders. The test most recommended for diagnosing osteoporosis is measurement of bone mineral density by means of dual energy X-ray absorptiometry at two sites. Osteoporosis treatment has the aims of bone mass improvement and fracture control. A combination of calcium and vitamin D supplementation may reduce the risk of fractures. Antiresorptive medications act by blocking osteoclastic action and diminishing bone rebuilding. On the other hand, bone-forming drugs stimulate osteoblastogenesis, thereby stimulating the formation of bone matrix. Mixed-action medications are those that are capable of both stimulating bone formation and inhibiting reabsorption. Antiresorptive drugs form the group of medications with the greatest quantity of scientific evidence confirming their efficacy in osteoporosis treatment. Physical activity is a health promotion strategy for the general population, but only preliminary data on its real value and benefit among PLWHIV are available, especially in relation to osteoporosis.

Are you interested in

Mail us at

Enquiry
std-aids@alliedsummit.org
General Queries
std-aidscongress@alliedconferences.org
Sponsors/Exhibitors
std-aids@alliedsummit.org
More details about sponsorship:sponsors@alliedacademies.com
Copyright © 2018-2019 Allied Academies, All Rights Reserved.